Enlivex Therapeutics (Israel) Probability of Future Stock Price Finishing Under 448.43
| ENLV Stock | ILA 456.10 0.90 0.20% |
Enlivex |
Enlivex Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Enlivex Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Enlivex Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Enlivex Therapeutics generated a negative expected return over the last 90 days | |
| Enlivex Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (14.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Enlivex Therapeutics has accumulated about 90.6 M in cash with (17.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.95. | |
| Roughly 12.0% of the company shares are held by company insiders |
Enlivex Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Enlivex Stock often depends not only on the future outlook of the current and potential Enlivex Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enlivex Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.3 M | |
| Shares Float | 14.3 M |
Enlivex Therapeutics Technical Analysis
Enlivex Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Enlivex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Enlivex Therapeutics. In general, you should focus on analyzing Enlivex Stock price patterns and their correlations with different microeconomic environments and drivers.
Enlivex Therapeutics Predictive Forecast Models
Enlivex Therapeutics' time-series forecasting models is one of many Enlivex Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Enlivex Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Enlivex Therapeutics
Checking the ongoing alerts about Enlivex Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Enlivex Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Enlivex Therapeutics generated a negative expected return over the last 90 days | |
| Enlivex Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (14.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Enlivex Therapeutics has accumulated about 90.6 M in cash with (17.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.95. | |
| Roughly 12.0% of the company shares are held by company insiders |
Additional Information and Resources on Investing in Enlivex Stock
When determining whether Enlivex Therapeutics is a strong investment it is important to analyze Enlivex Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Enlivex Therapeutics' future performance. For an informed investment choice regarding Enlivex Stock, refer to the following important reports:Check out Enlivex Therapeutics Backtesting, Enlivex Therapeutics Valuation, Enlivex Therapeutics Correlation, Enlivex Therapeutics Hype Analysis, Enlivex Therapeutics Volatility, Enlivex Therapeutics History as well as Enlivex Therapeutics Performance. For information on how to trade Enlivex Stock refer to our How to Trade Enlivex Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.